Company
Every investor coverage indicates participated in a round George Clinical raised.
Companies George Clinical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming George Clinical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Federation and its unnamed co-investors have sold their indirect stakes in George Clinical to Hillhouse Capital, with the announcement made on Federation's own site. No price is disclosed.
The George Institute's commercial arm and its drug development company have secured $53 million from three Australian investors to speed commercialisation of medical research, with Brandon Capital's Ingmar Wahlqvist involved.